Synergistic Activity of Remdesivir-Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report.

Anna Gidari Samuele SabbatiniElisabetta SchiaroliSabrina Bastianelli Sara PierucciChiara BustiLavinia Maria SaracaLuca CapogrossiMaria Bruna PasticciDaniela Francisci

Published in: Viruses (2023)

Remdesivir-nirmatrelvir combination has synergic activity in vitro. This combination may have a role in immunosuppressed patients with severe COVID-19 and prolonged viral shedding.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
early onset
cancer therapy